Обозначение | Заглавие на русском языке | Статус | Язык документа | Цена (с НДС 20%) в рублях |
|
Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for venous whole blood - Part 1: Isolated cellular RNA
|
|
На языке оригинала
|
Пишите на gost@gostinfo.ru
|
|
|
Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for venous whole blood - Part 3: Isolated circulating cell free DNA from plasma
|
|
На языке оригинала
|
Пишите на gost@gostinfo.ru
|
|
|
Medical laboratories - Requirements for collection, transport,receipt, and handling of samples
|
|
На языке оригинала
|
Пишите на gost@gostinfo.ru
|
|
|
Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 1: Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases
|
|
На языке оригинала
|
Пишите на gost@gostinfo.ru
|
|
|
Clinical laboratory testing and in vitro diagnostic test systems - Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices - Part 2: Evaluation of performance of antimicrobial susceptibility test devices
|
|
На языке оригинала
|
Пишите на gost@gostinfo.ru
|
|
|
In vitro diagnostic medical devices - Clinical performance studies using specimens from human subjects - Good study practice
|
|
На языке оригинала
|
Пишите на gost@gostinfo.ru
|
|
|
In vitro diagnostic medical devices - Requirements for international harmonisation protocols establishing metrological traceability of values assigned to calibrators and human samples
|
|
На языке оригинала
|
Пишите на gost@gostinfo.ru
|
|
|
In vitro diagnostic medical devices - Multiplex molecular testing for nucleic acids - Part 1: Terminology and general requirements for nucleic acid quality evaluation
|
|
На языке оригинала
|
Пишите на gost@gostinfo.ru
|
|
|
In vitro diagnostic medical devices - Multiplex molecular testing for nucleic acids - Part 2: Validation and verification
|
|
На языке оригинала
|
Пишите на gost@gostinfo.ru
|
|
|
Medical laboratories - Application of risk management to medical laboratories
|
|
На языке оригинала
|
Пишите на gost@gostinfo.ru
|
|
|
Medical devices utilizing animal tissues and their derivatives - Part 1: Application of risk management
|
|
На языке оригинала
|
Пишите на gost@gostinfo.ru
|
|
|
Medical devices utilizing animal tissues and their derivatives - Part 2: Controls on sourcing, collection and handling
|
|
На языке оригинала
|
Пишите на gost@gostinfo.ru
|
|
|
Medical devices utilizing animal tissues and their derivatives - Part 3:Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy(TSE) agents
|
|
На языке оригинала
|
Пишите на gost@gostinfo.ru
|
|
|
Point-of-care testing(POCT) - Requirements for quality and competence
|
|
На языке оригинала
|
Пишите на gost@gostinfo.ru
|
|
|
In vitro diagnostic medical devices - Evaluation of stability of in vitro diagnostic reagents
|
|
На языке оригинала
|
Пишите на gost@gostinfo.ru
|
|
|
Biorisk management for laboratories and other related organisations
|
|
На языке оригинала
|
Пишите на gost@gostinfo.ru
|
|
|
Biological evaluation of medical devices - Part 22: Guidance on nanomaterials
|
|
На языке оригинала
|
Пишите на gost@gostinfo.ru
|
|
|
Biological evaluation of medical devices - Part 33: Guidance on tests to evaluate genotoxicity - Supplement to ISO 10993-3
|
|
На языке оригинала
|
Пишите на gost@gostinfo.ru
|
|
|
Medical devices utilizing animal tissues and their derivatives - Part 4: Principles for elimination and/or inactivation of transmissible spongiform encephalopathy(TSE) agents and validation assays for those processes
|
|
На языке оригинала
|
Пишите на gost@gostinfo.ru
|
|
|
Medical laboratories - Guidance on laboratory implementation of KS P ISO 15189:2006
|
|
На языке оригинала
|
Пишите на gost@gostinfo.ru
|
|
Страницы: 1 / 2 / 3 / 4 / 5 |